Filing Details

Accession Number:
0001209191-22-038181
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-17 19:56:02
Reporting Period:
2022-06-15
Accepted Time:
2022-06-17 19:56:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1468748 Kodiak Sciences Inc. KOD Biological Products, (No Disgnostic Substances) (2836) 270476525
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1754049 Jason Ehrlich 1200 Page Mill Road
Palo Alto CA 94304
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-06-15 5,494 $0.00 60,407 No 4 M Direct
Common Stock Disposition 2022-06-15 1,205 $7.21 59,202 No 4 S Direct
Common Stock Disposition 2022-06-17 2,282 $7.02 56,920 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2022-06-15 3,619 $0.00 3,619 $0.00
Common Stock Restricted Stock Units Disposition 2022-06-15 1,875 $0.00 1,875 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,238 No 4 M Direct
5,625 No 4 M Direct
Footnotes
  1. Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock.
  2. The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs on June 11, 2022. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).
  3. The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs on June 15, 2022. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).
  4. One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2020, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.
  5. One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.